Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 09:30AM ET
2.53
Dollar change
+0.01
Percentage change
0.31
%
Index- P/E- EPS (ttm)-4.43 Insider Own15.95% Shs Outstand4.96M Perf Week-5.95%
Market Cap12.55M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float4.17M Perf Month143.27%
Income-14.07M PEG- EPS next Q- Inst Own6.26% Short Float5.46% Perf Quarter351.71%
Sales11.16M P/S1.12 EPS this Y- Inst Trans-12.92% Short Ratio0.82 Perf Half Y503.82%
Book/sh2.92 P/B0.87 EPS next Y- ROA-22.04% Short Interest0.23M Perf Year136.45%
Cash/sh0.08 P/C30.61 EPS next 5Y- ROE-49.66% 52W Range0.22 - 3.20 Perf YTD355.86%
Dividend Est.- P/FCF11.01 EPS past 5Y37.78% ROI-48.49% 52W High-20.94% Beta2.32
Dividend TTM- Quick Ratio0.21 Sales past 5Y2.26% Gross Margin17.19% 52W Low1047.91% ATR (14)0.29
Dividend Ex-Date- Current Ratio0.21 EPS Y/Y TTM5.44% Oper. Margin-26.15% RSI (14)62.17 Volatility11.30% 20.32%
Employees207 Debt/Eq0.00 Sales Y/Y TTM-71.44% Profit Margin-126.02% Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q91.89% Payout0.00% Rel Volume0.01 Prev Close2.52
Sales Surprise- EPS Surprise- Sales Q/Q-100.00% Earnings- Avg Volume277.30K Price2.53
SMA202.68% SMA5078.16% SMA200208.14% Trades Volume184 Change0.31%
Mar-15-24 09:00AM
Nov-09-23 08:05AM
Sep-21-23 11:30AM
09:35AM
Aug-31-23 01:30PM
01:30PM Loading…
Aug-29-23 01:30PM
Aug-25-23 02:30PM
Aug-22-23 05:30PM
Aug-18-23 07:00PM
12:42PM
Jun-28-23 08:30AM
Apr-18-23 08:30AM
Apr-13-23 08:30AM
Mar-24-23 10:55AM
Mar-23-23 08:30AM
08:00AM Loading…
08:00AM
Mar-22-23 08:30AM
Feb-22-23 08:30AM
Jan-26-23 08:30AM
Jan-10-23 08:30AM
Sep-16-22 09:46AM
09:30AM
Jul-05-22 09:00AM
Jun-28-22 09:00AM
Jun-09-22 08:30AM
Jun-08-22 07:07AM
Jun-07-22 08:30AM
May-31-22 09:00AM
08:30AM
Apr-07-22 06:31PM
09:38AM Loading…
Jan-25-22 09:38AM
Jan-21-22 09:38PM
Jan-04-22 09:00AM
Dec-16-21 09:00AM
Dec-07-21 09:00AM
Nov-08-21 06:58AM
Oct-27-21 09:00AM
Oct-19-21 09:00AM
Oct-12-21 09:00AM
Oct-07-21 09:00AM
Sep-30-21 09:00AM
Sep-28-21 04:05PM
Jul-22-21 09:45AM
Jun-23-21 10:10AM
Jun-22-21 09:46AM
Jun-15-21 10:15AM
Jun-10-21 10:15AM
Jun-08-21 09:45AM
Feb-25-21 09:29AM
Feb-02-21 11:45AM
Jan-29-21 08:45AM
Sep-24-20 10:45AM
Sep-22-20 09:45AM
Sep-16-20 02:37PM
Sep-03-20 10:30AM
Aug-31-20 05:00PM
Aug-28-20 02:34PM
Aug-26-20 09:45AM
Aug-21-20 10:31AM
Aug-19-20 02:50PM
Aug-11-20 07:00PM
Aug-06-20 02:30PM
Aug-04-20 09:47AM
Jul-30-20 09:30AM
Jul-21-20 09:25AM
Jul-08-20 09:30AM
Jun-30-20 09:30AM
Jun-25-20 02:23PM
Jun-18-20 09:27AM
Feb-06-20 09:02AM
Jan-28-20 09:02AM
Jan-23-20 09:02AM
Jan-16-20 10:51AM
Dec-03-19 09:03AM
Nov-25-19 09:00AM
Sep-12-19 08:00AM
Sep-11-19 08:03AM
JanOne, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.